Why the study?
Presence of autoantibodies against cTnI or cTnT interferes with troponin assays, but the extent of interference with measurement has not been explored sufficiently.
What are the frequencies of autoantibodies against troponin I and T, and do they significantly interfere with troponin assays in patients with suspected ischemic heart disease?
What are the frequencies of autoantibodies against troponin I and T, and do they significantly interfere with troponin assays in patients with suspected ischemic heart disease?
Autoantibodies against troponin I are relatively common (15.4%) but do not significantly interfere with the discrepancy between troponin I and T assays.
Autoantibody screening not indicated by current data; leaves open contribution to troponin assay discrepancies in suspected ischemic heart disease.
Objective Presence of autoantibodies against troponin I (cTnI) or T (cTnT) has been reported to interfere with troponin assays. However, the extent of the interference with the measurement has not been explored sufficiently. The aims of this study were to examine the frequencies of autoantibodies against troponin I and troponin T and how much these antibodies would affect the measurement. Methods The study comprised 52 subjects who visited Hokkaido University Hospital with suspected ischemic heart diseases. To evaluate the presence of autoantibodies, we calculated the recoveries of cTnI or cTnT after immunoglobulin G depletion, and the distributions of peaks reactive with cTnI or cTnT by high-performance liquid chromatography were examined. Results Autoantibodies against cTnI and cTnT were identified in 8 subjects (15.4%) and 1 subject (1.9%), respectively. Although the greatest difference between cTnI and cTnT was 32-fold, the distributions of cTnI-to-cTnT ratios in groups with and without anti-cTnI were not statistically different. Conclusion Autoantibodies against cTnI were more frequent by several fold than those against cTnT. Their presence did not significantly expand the discrepancy between cTnI and cTnT assays.
No takes yet. Share an insight, caveat, or question.
Nakano et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: